Key result
Treatment of atrial fibrillation with the implantable Atrioverter restored sinus rhythm in 92% of episodes, with sedation required in only 12% of episodes.
Why the study?
Can atrial fibrillation be treated with an implantable atrial defibrillator without the need for sedation?
Observational (n=12)
Can atrial fibrillation be treated with an implantable atrial defibrillator without the need for sedation?
Internal atrial defibrillation can be successfully performed without sedation in selected patients, particularly when episodes require two or fewer shocks.
Answers are grounded in this paper and cite their sources.
Should not yet change AF cardioversion practice; leaves open sedation-sparing role for implantable devices in future trials.
BACKGROUND: The low shock energy used during internal atrial defibrillation may decrease the need for sedation during defibrillation with an implantable atrial defibrillator. METHODS AND RESULTS: The atrial defibrillator (Metrix Atrioverter) was implanted in 12 patients. During the in-hospital treatment of atrial fibrillation (AF) episodes, intravenous sedation was given only on patient request. The Atrioverter was programmed for ambulatory therapy in 4 patients. Efficacy, number of shocks delivered, and sedation requirements were recorded. A total of 393 shocks (1.8+/-1. 6 shocks/AF episode) were delivered to treat 213 AF episodes; 85 of 213 AF episodes (40%) were treated away from the hospital. Sinus rhythm was restored in 195 AF episodes (92%). Five patients never requested sedation. No sedation was needed for ambulatory-treated AF episodes. During the treatment of 26 of 213 AF episodes (12%), 75 shocks were delivered after patients received sedation. The number of shocks required to treat an AF episode determined the need for sedation (4.3+/-2.1 shocks for AF episodes requiring sedation versus 2+/-1 shocks for AF episodes requiring no sedation; P<0.001). These additional shocks were needed to treat immediate reinitiation of AF (14 episodes) or initial failure to cardiovert (4 episodes). For 8 AF episodes, sedation was requested before the first shock. CONCLUSIONS: This study suggests that, in a selected group of patients, AF can be treated with Atrioverter therapy without sedation. Successful ambulatory treatment of AF episodes with the Atrioverter, programmed to deliver </=2 shocks, did not require sedation. When multiple shocks were required to treat an AF episode, the need for sedation increased and included patients initially not requesting sedation.
No takes yet. Share an insight, caveat, or question.
Timmermans et al. (1999) conducted an observational in Atrial fibrillation (n=12). Implantable atrial defibrillator (Metrix Atrioverter) was evaluated on Restoration of sinus rhythm. Treatment of atrial fibrillation with the implantable Atrioverter restored sinus rhythm in 92% of episodes, with sedation required in only 12% of episodes.
Synapse has enriched 10 related papers. Consider them for comparative context: